APA citiranje

Aoki, T., Arakawa,, Ueba,, Oda,, Nishida,, Akiyama,, . . . Miyamoto. (2017). P09.01 Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group. Neuro Oncol.

Citação norma Chicago

Aoki, T., et al. "P09.01 Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group." Neuro Oncol 2017.

MLA citiranje

Aoki, T., et al. "P09.01 Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group." Neuro Oncol 2017.